Insider · CIK 0001981291
Abhinav Jain
Files at AYTU (AYTU BIOPHARMA, INC), TLPH (ACELRX PHARMACEUTICALS INC), XTNT (Xtant Medical Holdings, Inc.). First filing -, latest -.
In brief
Abhinav Jain files SEC Form 4 as director at AYTU (AYTU BIOPHARMA, INC), and also at TLPH (ACELRX PHARMACEUTICALS INC), XTNT (Xtant Medical Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Abhinav Jain has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 15, 2026 | XTNT Xtant Medical Holdings, Inc. | AGrant or award Common Stock | +215,517 | $0.00 | $0 | 373,745 | Aug 18, 2026 |
| Jul 28, 2026 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 29,500 | Jul 30, 2026 |
| Jun 22, 2026 | TLPH ACELRX PHARMACEUTICALS INC | AGrant or award Common Stock | +5,100 | $0.00 | $0 | 12,412 | Jun 24, 2026 |
| Jun 22, 2026 | TLPH ACELRX PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +30,700 | $0.00 | $0 | 30,700 | Jun 24, 2026 |
| Nov 15, 2025 | XTNT Xtant Medical Holdings, Inc. | AGrant or award Common Stock | +158,228 | $0.00 | $0 | 158,228 | Nov 18, 2025 |
| Oct 23, 2025 | TLPH ACELRX PHARMACEUTICALS INC | AGrant or award Common Stock | +4,267 | $0.00 | $0 | 7,312 | Oct 24, 2025 |
| Oct 23, 2025 | TLPH ACELRX PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +25,600 | $0.00 | $0 | 25,600 | Oct 24, 2025 |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 19,500 | Oct 7, 2025 |
| Nov 6, 2024 | AYTU AYTU BIOPHARMA, INC | AGrant or award Common Shares | +1,500 | $0.00 | $0 | 9,500 | Nov 8, 2024 |
Questions about Abhinav Jain
Answered from the filings on this page, as of the latest one.
Is Abhinav Jain buying or selling?
Abhinav Jain has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Abhinav Jain's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Abhinav Jain has 0.
Where does Abhinav Jain file Form 4?
Abhinav Jain has filed Form 4 at AYTU (AYTU BIOPHARMA, INC); TLPH (ACELRX PHARMACEUTICALS INC); XTNT (Xtant Medical Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.